1. Announce Data @ 7/31 Summit 2. Revenue Guidanc
Post# of 30028
Posted On: 07/22/2014 9:21:32 PM
1. Announce Data @ 7/31 Summit
2. Revenue Guidance during Q2 CC (usually around 8/15 to 8/20
3. Announce Partner for Lympro (note: I believe the partner & AMBS are simply completing the paperwork at this stage...not unusual for a deal of this magnitude & complexity to take months to complete).
Looking for ramp up to 07/31 summit, continued upward bias through first two weeks of August, spike after revenue guidance, and large increase upon partnership announcement. I expect .50 to .75 eod 08/29.
IMO, agreement with LPC to purchase shares in open market is also a warning to small-time bear-raiders: Do Not Attempt!
VO
2. Revenue Guidance during Q2 CC (usually around 8/15 to 8/20
3. Announce Partner for Lympro (note: I believe the partner & AMBS are simply completing the paperwork at this stage...not unusual for a deal of this magnitude & complexity to take months to complete).
Looking for ramp up to 07/31 summit, continued upward bias through first two weeks of August, spike after revenue guidance, and large increase upon partnership announcement. I expect .50 to .75 eod 08/29.
IMO, agreement with LPC to purchase shares in open market is also a warning to small-time bear-raiders: Do Not Attempt!
VO
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼